CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to target glioblastomas, the most aggressive brain tumors, by inhibiting a specific immune checkpoint. The research will explore the effects of this inhibition on tumor cells and their environment, potentially leading to new therapeutic strategies.
The brain is our most precious organ.
Not only does it orchestrate vital body functions but it also stores memories and experiences, ultimately defining the core of our human nature.
Brain malignancies are particularly disheartening because they disrupt our ability to perform as individuals and hinder our social interactions.
Glioblastomas (GBs) represent the most frequent and lethal form of primary brain tumors, with a median survival of 14.6 months and 15,000 newly diagnosed patients per year…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
